Skip to main content

Tag: psychiatric diagnosing

The Boy Who Burned Too Brightly

This book is an excellent resource for parents, teachers, school counselors and anyone that works with children. It is an allegorical tale that paints an excellent picture of what it’s like for children diagnosed with ADD, ADHD and other psychiatric labels, and how these children are treated in the school system. The Boy Who Burned Too Brightly, written by David J. Welsh, is a fiction story about a town where everyone has a flame burning on the top of their head. Randall is a boy who is unique and his parents love that about him and don’t think there is anything wrong until a teacher points out the brightness of his flame and he is then brought to a “child pyrologist” who diagnoses him with Defective Flicker Syndrome.

In the book, Randall is then medicated with a drink called “quiescence,” which is representative of the psychiatric drugs such as Ritalin, Adderall, Prozac and Zoloft that millions of children are prescribed in our world today. In The Boy Who Burned Too Brightly, Randall’s differentness is suppressed, and those around him want his behavior to be more consistent with those around him, instead of magnifying his special and unique attributes and letting them truly shine. The book shows that to some people a flame may be too bright, but to others, brightness is a true gift that should be encouraged and shone to the world.

About the Author

Dr. David J. Welsh is an educational psychologist who has been in private practice in Forth Worth, Texas since 1985. Aside from writing books, he was also a producer and host of a show called Issues of the Mind from 1987 to 1997. He received his bachelor’s degree from Colorado State University in 1975, then went on to get his master’s degree in educational psychology from the University of Nebraska at Omaha in 1978, and was awarded his PhD in educational psychology from the University of Texas in 1984. Dr. Welsh is a member of the American Psychological Association and Texas Psychological Association. He is also a former president of the Tarrant County Psychological Association.

Reviews

Jane L. Brown, RN, Center for Effective Learning, Virginia Beach, VA:

“I missed several words on my first read–I had tears in my eyes. It’s absolutely wonderful!”

Ron Rubin, Center for Developmental Disabilities, Univ. of Vermont:

“In a world that espouses honoring diversity, it stands out as a heart-felt treatment of what ‘honoring’ truly means.”

La Nelle Gallagher, Learning Disabilities Association of Texas:

“This book is probably the most creative and clever book on learning differences I have ever read!”

Author Dr. Thomas Armstrong:

“Certainly hits the nail on the head. I enjoyed reading it and will share this book with others.”

Did Psychiatric Drugs Play a Role in Plaskon’s Violent Behavior?

The alleged “Prom day” killer, Christopher Plaskon, is a snap shot of the future result of Connecticut’s increased mental health services.  The 17 year-olds defense apparently will be that his “mental health” caused his murderous actions – not the dangerous psychiatric drugs he obviously has been taking for some time.

Early reports of Plaskon’s behavior included information that he had been taking drugs to treat the alleged ADHD.  What psychiatric drugs? When was the teenager first diagnosed? Had he been further diagnosed with additional “mental illnesses?”  Which diagnoses?  How many psychiatric drugs had the teenager been prescribed during his young life?  Had Plaskon been taking a “cocktail” of psychiatric drugs?  All of these questions are important to understanding Plaskon’s violent actions.   Here’s why.

The teenager is mentally ill. He suffers from one or more psychiatric disorders.   This is the mental health community’s mantra and “ace in the hole.”   Despite there being zero scientific or medical data to support even one psychiatric “disorder” being an abnormality of the brain (objective, confirmable abnormality), the mental health community’s psychiatric labeling goes unchecked, opening the flood gates for prescribing dangerous psychiatric drug “treatments.”

According to recent news reports, Plaskon is being “treated” with two mind-altering psychiatric drugs – an anti-anxiety drug and also an anti-psychotic.  How long has Plaskon been taking these drugs? Had the teenager been prescribed the mind-altering drugs prior to his murderous actions?

For the sake of argument, let’s assumed Plaskon was being “treated” with both the anti-anxiety and anti-psychotic drugs prior to the stabbing.  Had he, like the Santa Barbara shooter, been prescribed the anti-anxiety drug, Xanax?  What are some of the known serious adverse reactions associated with anti-anxiety drugs like Xanaz?  Confusion, hallucinations, unusual thoughts or behavior, thoughts of suicide or hurting yourself, aggression, hostility and decreased inhibitions are some of the more serious adverse reactions associated with this class of drug.

What about the adverse reactions associated with anti-psychotic drugs?  Like so many of the psychiatric drug “treatments,” known adverse reactions associated with antipsychotic drugs include increased anxiety, depression and suicidal thoughts, to name a few.

Given the known adverse reactions associated with these psychiatric drugs, and withdrawal from them, it seems fair to suggest that it’s possible that Plaskon’s violent behavior may have been a result of one or more of the adverse reactions associated with these psychiatric drugs.

Will Plaskon’s psychiatric drug use even be made part of the trial? If history is any indication, probably not. The mental health community, which cannot prove even one of its alleged mental disorders is an abnormality of the brain and,  which, the state of Connecticut has warmly embraced will effectively and without scrutiny argue the worsening of Plaskon’s mental disorders.

As Ablechild’s mission is one of informed consent, we cannot help but wonder if Plaskon’s parents were made aware of the complete subjectivity of psychiatric diagnosing or, for that matter, advised of the possible known adverse reactions associated with any psychiatric drugs their son may have been prescribed.  This information can be easily verified by the informed consent document parents should sign when the diagnosis is made, like the one linked.

Because of the state’s ill-informed rush to institute costly, increased mental health services in Connecticut, and being fully aware that mental health “treatment” largely consists of prescribing psychiatric drugs, Ablechild believes that the state has an obligation to insure that parents and families are fully informed on both of these issues.

It’s one thing to tell consumers that the mental health increases are being instituted  to help those who are “suffering.” But without providing all the information about psychiatric diagnosing and the risks associated with psychiatric drugs, the state is nothing more than a shill for the mental health community and pharmaceutical industry.